Kendra L. Congdon, Ph.D. - Publications

Affiliations: 
2008 Duke University, Durham, NC 
Area:
Cell Biology

13/26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH. Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 26759007 DOI: 10.1007/S00262-015-1784-3  0.32
2015 Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 519: 366-9. PMID 25762141 DOI: 10.1038/Nature14320  0.32
2014 Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH. Epidermal growth factor receptor and variant III targeted immunotherapy. Neuro-Oncology. 16: viii20-5. PMID 25342601 DOI: 10.1093/Neuonc/Nou236  0.32
2013 Congdon KL, Sampson JH. Enhanced oncolytic virotherapy through oxidative stress inhibition. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1981-3. PMID 24201213 DOI: 10.1038/Mt.2013.227  0.32
2013 Lento W, Congdon K, Voermans C, Kritzik M, Reya T. Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harbor Perspectives in Biology. 5. PMID 23378582 DOI: 10.1101/Cshperspect.A008011  0.48
2012 Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, et al. A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. Plos One. 7: e31046. PMID 22383993 DOI: 10.1371/Journal.Pone.0031046  0.32
2011 Mitchell DA, Cui X, Schmittling RJ, Sanchez-Perez L, Snyder DJ, Congdon KL, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, et al. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood. 118: 3003-12. PMID 21768296 DOI: 10.1182/Blood-2011-02-334565  0.32
2010 Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim SH, Kim DW, Chuah C, et al. Regulation of myeloid leukaemia by the cell-fate determinant Musashi. Nature. 466: 765-8. PMID 20639863 DOI: 10.1038/Nature09171  0.32
2008 Congdon KL, Reya T. Divide and conquer: how asymmetric division shapes cell fate in the hematopoietic system. Current Opinion in Immunology. 20: 302-7. PMID 18554882 DOI: 10.1016/J.Coi.2008.05.003  0.48
2008 Congdon KL, Voermans C, Ferguson EC, DiMascio LN, Uqoezwa M, Zhao C, Reya T. Activation of Wnt signaling in hematopoietic regeneration. Stem Cells (Dayton, Ohio). 26: 1202-10. PMID 18308947 DOI: 10.1634/Stemcells.2007-0768  0.48
2005 Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, Yoon K, Cook JM, Willert K, Gaiano N, Reya T. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nature Immunology. 6: 314-22. PMID 15665828 DOI: 10.1038/Ni1164  0.32
2004 Brady GF, Congdon KL, Clark AG, Sackey FN, Rudolph EH, Radic MZ, Foster MH. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. Journal of Immunology (Baltimore, Md. : 1950). 172: 5313-21. PMID 15100270 DOI: 10.4049/Jimmunol.172.9.5313  0.32
2002 Rudolph EH, Congdon KL, Sackey FN, Fitzsimons MM, Foster MH. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. Journal of Immunology (Baltimore, Md. : 1950). 168: 5943-53. PMID 12023401 DOI: 10.4049/Jimmunol.168.11.5943  0.32
Low-probability matches
2010 Ito T, Kwon HY, Zimdahl B, Congdon KL, Blum J, Lento WE, Zhao C, Lagoo A, Gerrard G, Foroni L, Goldman J, Goh H, Kim S, Kim D, Chuah C, et al. P73. Regulation of myeloid leukemia by the cell fate determinant Musashi Differentiation. 80: S41. DOI: 10.1016/J.Diff.2010.09.079  0.08
2021 Swartz AM, Congdon KL, Nair SK, Li QJ, Herndon JE, Suryadevara CM, Riccione KA, Archer GE, Norberg PK, Sanchez-Perez LA, Sampson JH. A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope. Npj Vaccines. 6: 12. PMID 33462231 DOI: 10.1038/s41541-020-00273-5  0.01
2019 Peters KB, Archer GE, Norberg P, Xie W, Threatt S, Lipp ES, Herndon JE, Healy P, Congdon K, Sanchez-Perez L, Friedman HS, Desjardins A, Vlahovic G, Sampson JH. Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma. Journal of Clinical Oncology. 37: e13526-e13526. DOI: 10.1200/Jco.2019.37.15_Suppl.E13526  0.01
2019 Peters K, Congdon K, Archer G, Woodring S, Jaggers D, Lipp E, Healy P, Herndon J, Soher B, Vlahovic G, Johnson M, Randazzo D, Desjardins A, Friedman H, Friedman A, et al. ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS Neuro-Oncology. 21: vi8-vi8. DOI: 10.1093/Neuonc/Noz175.030  0.01
2018 Congdon KL, Sanchez-Perez LA, Sampson JH. Effective Effectors: How T cells Access and Infiltrate the Central nervous System. Pharmacology & Therapeutics. PMID 30557632 DOI: 10.1016/J.Pharmthera.2018.12.007  0.01
2018 Riccione KA, He LZ, Fecci PE, Norberg PK, Suryadevara CM, Swartz A, Healy P, Reap E, Keler T, Li QJ, Congdon KL, Sanchez-Perez L, Sampson JH. CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. Oncoimmunology. 7: e1502904. PMID 30524899 DOI: 10.1080/2162402X.2018.1502904  0.01
2018 Swartz AM, Shen SH, Salgado MA, Congdon KL, Sanchez-Perez L. Promising vaccines for treating glioblastoma. Expert Opinion On Biological Therapy. PMID 30281978 DOI: 10.1080/14712598.2018.1531846  0.01
2018 Atik AF, Suryadevara CM, Schweller RM, West JL, Healy P, Herndon Ii JE, Congdon KL, Sanchez-Perez L, McLendon RE, Archer GE, Fecci P, Sampson JH. Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 30041899 DOI: 10.1016/J.Jocn.2018.06.005  0.01
2018 Congdon KL, Sanchez-Perez LA, Sampson JH. Abstract CN02-02: Immunotherapy for central nervous system cancers Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Cn02-02  0.01
2018 Batich K, Ashley D, Archer G, Sanchez-Perez L, Norberg P, Congdon K, Herndon J, McSherry F, Gemberling S, Hesler R, Jaggers D, Van R, Parker J, Peters K, Desjardins A, et al. RBTT-02. ENHANCING VACCINE RESPONSES WITH DOSE-INTENSIFIED TEMOZOLOMIDE IN GLIOBLASTOMA: INITIATION OF THE I-ATTAC TRIAL Neuro-Oncology. 20: vi234-vi234. DOI: 10.1093/Neuonc/Noy148.972  0.01
2018 Batich K, Sanchez-Perez L, Schaller T, Cui X, Xie W, Archer G, Norberg P, Snyder D, Congdon K, Sampson J. IMMU-23. ANTIGEN-SPECIFIC EFFECTOR MEMORY CD4+ T CELLS AND CCL3 POTENTIATE DENDRITIC CELL VACCINES AND ANTITUMOR IMMUNITY Neuro-Oncology. 20: vi126-vi126. DOI: 10.1093/Neuonc/Noy148.526  0.01
2017 Wu Y, Norberg PK, Reap EA, Congdon KL, Fries CN, Kelly SH, Sampson JH, Conticello VP, Collier JH. A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers. Acs Biomaterials Science & Engineering. 3: 3128-3132. PMID 30740520 DOI: 10.1021/Acsbiomaterials.7B00561  0.01
2017 Reap E, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, et al. Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma. Cancer Research. PMID 29093005 DOI: 10.1158/0008-5472.Can-17-0469  0.01
Hide low-probability matches.